Announcement on Reply to Inquiry Letter for Information Disclosure Supervision of 2024 Annual Report

About this update from Hpgc Renmintongtai Pharmaceutical Corporation Class A

Announcement on Reply to Inquiry Letter for Information Disclosure Supervision of 2024 Annual ReportThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Hpgc Renmintongtai Pharmaceutical Corporation Class A